Outlook Therapeutics
OTLK
#9492
Rank
โ‚ฌ44.59 M
Marketcap
1,37ย โ‚ฌ
Share price
5.41%
Change (1 day)
-83.92%
Change (1 year)

EPS for Outlook Therapeutics (OTLK)

EPS in 2023 (TTM): -0,24ย โ‚ฌ

According to Outlook Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,22ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,27ย โ‚ฌ an increase over its 2021 EPS that were of -0,28ย โ‚ฌ.

EPS history for Outlook Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,24ย โ‚ฌ-12.85%
2022-0,27ย โ‚ฌ-3.13%
2021-0,28ย โ‚ฌ-45.58%
2020-0,52ย โ‚ฌ-72.76%
2019-1,89ย โ‚ฌ-69.86%
2018-6,28ย โ‚ฌ-42.98%
2017-11,01ย โ‚ฌ-45.12%
2016-20,05ย โ‚ฌ-32.39%
2015-29,66ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,63ย โ‚ฌ 644.00% Jersey
-6,30ย โ‚ฌ 2,776.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,81ย โ‚ฌ 724.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-5,43ย โ‚ฌ 2,380.00%๐Ÿ‡ฌ๐Ÿ‡ง UK